5 Stocks Pushing The Health Services Industry Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 17 points (0.1%) at 13,052 as of Thursday, Dec. 6, 2012, 11:50 AM ET. The NYSE advances/declines ratio sits at 1,459 issues advancing vs. 1,413 declining with 145 unchanged.

The Health Services industry currently sits up 0.2% versus the S&P 500, which is up 0.2%. Top gainers within the industry include Bio-Reference Labs ( BRLI), up 5.4%, ResMed ( RMD), up 1.2%, Mindray Medical International ( MR), up 1.2%, Universal Health Services ( UHS), up 1.2% and Edwards Life ( EW), up 0.9%. A company within the industry that fell today was Baxter International ( BAX), up 0.6%.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry higher today:

5. Life Technologies ( LIFE) is one of the companies pushing the Health Services industry higher today. As of noon trading, Life Technologies is up $0.62 (1.3%) to $49.59 on light volume Thus far, 352,104 shares of Life Technologies exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $48.82-$49.65 after having opened the day at $49.06 as compared to the previous trading day's close of $48.97.

Life Technologies Corporation operates as a global life sciences company. Life Technologies has a market cap of $8.4 billion and is part of the health care sector. The company has a P/E ratio of 21.4, above the S&P 500 P/E ratio of 17.7. Shares are up 25.7% year to date as of the close of trading on Wednesday. Currently there are 10 analysts that rate Life Technologies a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Life Technologies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, reasonable valuation levels, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Life Technologies Ratings Report now.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass

If you liked this article you might like

7 Stocks Under $10 Making Big Moves Higher

These 5 Stocks Are Breaking Out

5 Stocks With Big Insider Buying

Here’s A Reason aTyr Pharma (LIFE) Stock is Rising Today

5 Stocks Poised for Breakouts